These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16837065)

  • 21. Altered T cell differentiation associated with loss of CD27 and CD28 in HIV infected Indian individuals.
    Mojumdar K; Vajpayee M; Chauhan NK; Singh A; Singh R; Kurapati S
    Cytometry B Clin Cytom; 2012 Jan; 82(1):43-53. PubMed ID: 21695776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28-CD8+ T Cells.
    Leitner J; Herndler-Brandstetter D; Zlabinger GJ; Grubeck-Loebenstein B; Steinberger P
    J Immunol; 2015 Jul; 195(2):477-87. PubMed ID: 26041540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin content.
    Ye SW; Wang Y; Valmori D; Ayyoub M; Han Y; Xu XL; Zhao AL; Qu L; Gnjatic S; Ritter G; Old LJ; Gu J
    J Clin Immunol; 2006 Sep; 26(5):447-56. PubMed ID: 16967323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease.
    Barathan M; Mohamed R; Saeidi A; Vadivelu J; Chang LY; Gopal K; Ram MR; Ansari AW; Kamarulzaman A; Velu V; Larsson M; Shankar EM
    Eur J Clin Invest; 2015 May; 45(5):466-74. PubMed ID: 25721991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological mechanisms underlying delayed-type hypersensitivity reactions to glatiramer acetate.
    Mayorga C; Blazquez AB; Doña I; Gomez F; Chaves P; Sanchez-Quintero MJ; Blanca-López N; Melendez L; Blanca M; Torres MJ
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):47-51. PubMed ID: 22727157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-15 preferentially enhances functional properties and antigen-specific responses of CD4+CD28(null) compared to CD4+CD28+ T cells.
    Alonso-Arias R; Moro-García MA; Vidal-Castiñeira JR; Solano-Jaurrieta JJ; Suárez-García FM; Coto E; López-Larrea C
    Aging Cell; 2011 Oct; 10(5):844-52. PubMed ID: 21635686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones.
    Posnett DN; Edinger JW; Manavalan JS; Irwin C; Marodon G
    Int Immunol; 1999 Feb; 11(2):229-41. PubMed ID: 10069421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
    Sellebjerg F; Hesse D; Limborg S; Lund H; Søndergaard HB; Krakauer M; Sørensen PS
    Mult Scler; 2013 Feb; 19(2):179-87. PubMed ID: 22653658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis.
    Tennakoon DK; Mehta RS; Ortega SB; Bhoj V; Racke MK; Karandikar NJ
    J Immunol; 2006 Jun; 176(11):7119-29. PubMed ID: 16709875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.
    Bratke K; Kuepper M; Bade B; Virchow JC; Luttmann W
    Eur J Immunol; 2005 Sep; 35(9):2608-16. PubMed ID: 16106370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy-induced changes and immunosenescence of CD8+ T-cells in patients with breast cancer.
    Onyema OO; Decoster L; Njemini R; Forti LN; Bautmans I; De Waele M; Mets T
    Anticancer Res; 2015 Mar; 35(3):1481-9. PubMed ID: 25750301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric detection of degranulation reveals phenotypic heterogeneity of degranulating CMV-specific CD8+ T lymphocytes in rhesus macaques.
    Chan KS; Kaur A
    J Immunol Methods; 2007 Aug; 325(1-2):20-34. PubMed ID: 17628586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-specific cytotoxic T lymphocyte precursors exist in a CD28-CD8+ T cell subset and increase with loss of CD4 T cells.
    Lewis DE; Yang L; Luo W; Wang X; Rodgers JR
    AIDS; 1999 Jun; 13(9):1029-33. PubMed ID: 10397532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease.
    Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir MS; Feki M; Hamzaoui K
    Mediators Inflamm; 2004 Aug; 13(4):247-53. PubMed ID: 15545055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
    Navarro J; Resino S; Bellón JM; Abad ML; Gurbindo D; Fernández-Cruz E; Muñóz-Fernández MA
    AIDS Res Hum Retroviruses; 2001 Apr; 17(6):525-32. PubMed ID: 11350666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.
    Porakishvili N; Kardava L; Jewell AP; Yong K; Glennie MJ; Akbar A; Lydyard PM
    Haematologica; 2004 Apr; 89(4):435-43. PubMed ID: 15075077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.
    Echeverría A; Moro-García MA; Asensi V; Cartón JA; López-Larrea C; Alonso-Arias R
    J Leukoc Biol; 2015 Sep; 98(3):373-84. PubMed ID: 26034206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expansion of a peripheral blood perforin+ CD8+ T-cell subset in long-term surviving lung transplanted patients.
    Berthou C; Legros-Maïda S; Soulié A; Wargnier A; Guillet J; Lafaurie C; Stern M; Sasportes M; Israël-Biet D
    Transplant Proc; 1996 Jun; 28(3):1964-7. PubMed ID: 8658962
    [No Abstract]   [Full Text] [Related]  

  • 40. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.